medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2022, Number 4

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2022; 20 (4)

Subcutaneous fat necrosis in a newborn. A case report

Aguilera MV, Rostro HMA, Ramos-Garibay A

Language: Spanish
References: 13
Page: 441-444
PDF size: 197.29 Kb.


ABSTRACT

Subcutaneous fat necrosis of the newborn is an uncommon lobular panniculitis, self-limited. The pathogenesis is unknown but the primary hypothesis suggest that local and systemic condition may induce subcutaneous hipoxemia and adipocyte necrosis. Hypercalcemia is a complication associated with significant mortality and morbidity. We present a case of an infant with no significant medical history and favorable evolution.


REFERENCES

  1. Stefanko NS y Drolet BA, Subcutaneous fat necrosis of the newbornand associated hipercalcemia: a systemic review of the literature, PediatricDermatology 2019; 36:24-30. doi:10.1111/pde.13640.

  2. Mitra S, Dove J y Kumar SS, Subcutaneous fat necrosis in newborn:an unusual case and review of literature, Eur J Pediatr 2011; 170:1107-10.doi: 10.1007/s00431-1405-x.

  3. Mehta S, Parkash GN, Batra A y Sharma R, Subcutaneous fat necrosisin an infant with hypoxic ischaemic encephalopathy stage 3: anuncommon association, bmj Case Rep 2021; 14:e237933. doi: 10.1136/bcr-2020-237933.

  4. López HD, Delgado ME, Ortega DJ, Solís AM, Carmona AH y CabelloDC, Necrosis grasa del recién nacido, Rev Chil Pediatr 2020; 91(1):94-8.doi: 10.32641/rchped.v91i1.1168.

  5. Pérez-Elizondo AD y Valdés López A, Necrosis grasa subcutánea delrecién nacido. Presentación de un caso, Arch Inv Mat Inf 2019; X(1):34-6.Disponible en: http://www.medigraphic.com/maternoinfantil.

  6. Del Pozzo BR y Ho N, Subcutaneous fat necrosis of the newborn:a 20-year retrospective study, Pediatric Dermatology 2016; 1-3. doi:10.1111/pde.12973.

  7. González LL, Vicente VA, Otero RM, Rivas O, Suno CM, Prada F yGonzález EM, Subcutabeous fat necrosis of the newborn: reportof five cases, Pediatrics and Neonatology 2017; 58:85-8. Disponible en:http://www.pediatric-neonatol.com.

  8. Shumer DE, Thaker V, Taylor GA y Wassner AJ, Severe hypercacemiadue to subcutaneous fat necrosis: presentation, management andcomplications, Arch Dis Child Fetal Neonatal Ed 2014; 99:F419-21. doi:10.1136/archdischild-2014-306069.

  9. Alsofyani KA, Neonatal subcutaneous fat necrosis with hipercalcemiatreatment using calcitonin, Saudi Med J 2018; 39(6):622-6. doi:

  10. 10.15537/smj.2018.6.22025.10. Ricardo-González RR, Lin JR, Mathes EF, McCalmont TH y Pincus LB,Neutrophil-rich subcutaneous fat necrosis of the newborn: a potentialmimic of infection, J Am Acad Dermatol 2016; 75(1):177-85. Disponibleen: http://dx.doi.org/10.1016/j.jaad.2016.02.1151.

  11. Guillen-Climent S, García VA, Estébanez A, Pons BM, Folch BR, VianaG et al., Necrosis grasa subcutánea del recién nacido: revisión clínica ehistopatológica y utilidad de la ecografía cutánea, Dermatology OnlineJournal 2020; 26(12):18. doi: 10.5070/D32611046542.

  12. Pérez ME, Camprubi CM, Ramos CM, Antón LJ, Apodaca SA, LópezRM et al., Treatment with bisphosphonates in severe hypercalcemiadue to subcutaneous fat necrosis in an infant with hypoxic-ischemicencephalopathy, Journal of Perinatology 2014; 34:492-3. doi; 10.1038/jp.2014.28.

  13. Hakan N, Aydin M, Zenciroglu A, Demirel N, Okumus N, CentinkayaS et al., Alendronate for treatment of hypercalcemia due to neonatalsubcutaneous fat necrosis, Eur J Pediatr 2011; 170:1085-6. doi: 10.1007/s00431-011-1468-8.




2020     |     www.medigraphic.com